Barocas, Charles – Trademark Portfolio
Entity Type: 01
Barocas, Charles has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as ROT and ELEVATING THE CLINICAL SPECIALTY IN ORTHOPEDICS. Filings span 3 Nice Classification classes, with the highest activity in Class 35 (Advertising & Business) and Class 42 (Computer & Scientific). This trademark owner is based in St. Petersburg, FL.
190 112th Ave. North, Suite 1505
St. Petersburg, FL 33716
Showing of trademarks Trademarks
Trademark Classifications
Barocas, Charles's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Barocas, Charles have?
Barocas, Charles has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does Barocas, Charles file in?
Barocas, Charles files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Barocas, Charles's most well-known trademarks?
Barocas, Charles's registered trademark portfolio includes well-known marks such as ROT and ELEVATING THE CLINICAL SPECIALTY IN ORTHOPEDICS. These are among 2 currently registered trademarks in the portfolio.
What is Barocas, Charles's trademark registration success rate?
Barocas, Charles has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.